D
Dr Lal PathLabs
The largest and most respected diagnostic service provider in India
About Dr Lal PathLabs
The story of Dr Lal PathLabs begins in 1949, a time of significant change in India. Dr. S.K. Lal, a pathologist trained in the British Indian Army, established a single pathology laboratory and blood bank in Delhi. He had a vision to provide authentic and reliable diagnostic services, a novel concept for a private enterprise at the time. The early years were focused on building a reputation for quality. A major turning point came in 1995 when the sole proprietorship was incorporated into a private limited company, setting the stage for structured growth. This was followed by a concerted effort to gain national and international accreditations in the early 2000s, solidifying its commitment to quality. In 2005, the company secured its first institutional investment from WestBridge Capital, which fueled a period of significant expansion, including strategic acquisitions. This growth trajectory continued, and in 2015, Dr Lal PathLabs launched its Initial Public Offering (IPO), getting listed on both the BSE and NSE. This event marked a new chapter for the company, providing capital for further nationwide expansion. Today, Dr Lal PathLabs operates a vast network of laboratories and patient service centers across India. The business functions on a hub-and-spoke model, with central reference labs supporting a wider network of regional and satellite centers to ensure efficiency and accessibility. Through strategic growth and a foundational commitment to quality, a single lab has transformed into a leading player in the Indian diagnostic landscape.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 1949
- Headquarters
- India
- Employees
- 7,430
- Open positions
- 20
- Dealroom signal
- 55.6/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Diabetes, Performance Management, Oncology, Patient Care, Pay Per Result
- Client focus
- b2b
- Investment activity
- 2 companies, latest Nov 2022
- Capital deployed
- —
- Preferred round
- SEED
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Other✓Other financing | Dec 2015 | $29M | — | JP Morgan · Reliance Capital · Fidelity Investments · State Bank of India | — |
| SEED✓Equity / VC | Aug 2010 | $0 | — | TA Associates | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Dr Lal PathLabs is 2.2M monthly website visits, up 100% over the last three months. Dr Lal PathLabs's team grew 81.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Neuome Technologies Private LimitedNew Delhi, IndiaCold chain-free biospecimen collection and storage technology
→
Artinci Artisanal FoodsBengaluru, IndiaArtinci Healthy Desserts and Snacks
$1.4Mvaluation
Suburban DiagnosticsMumbai, IndiaSuburban Diagnostics provide holistic diagnostic & pathology services across all our centers in MaharashtraWe also provide health check-ups
→
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
TA Associates
Other known investors6 additional known investors
- BIBirla Sun Life Insurance
Fidelity Investments
JP Morgan
Reliance Capital
State Bank of India
T. Rowe Price
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Dr Lal PathLabs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Dr Lal PathLabs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







